1. Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders
Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders (A) Increasing number of clinical studies testing “off‐label” calcineurin inhibitor use for the treatment of autoimmune disorders. Histograms show studies of tacrolimus and cyclosporine A as well as the year each study was completed or last updated (clinicaltrials.gov). (B) Graphical overview of the major autoimmune disorders targeted using calcineurin inhibitors.
Kamila Bendickova et al. EMBO Mol Med. 2017;emmm
© as stated in the article, figure or figure legend